Morepen Labs dip to 130-138 puts results in focus

Morepen Labs slides to ₹129 as dip-buy calls return

Morepen Laboratories Ltd (NSE: MOREPENLAB, BSE: 500288) became a high-chatter pharma name after a sharp pullback. Social posts pegged the stock around ₹129.55, down about 5.13% on the day. The move stood out because it followed a week of new 52-week and all-time highs cited in widely shared timelines. On NSE EOD (09-Oct-2026), the stock opened at ₹138.50, hit a high of ₹141.96, and dropped to a low of ₹127.14 before closing near ₹129.55. On BSE EOD, the close was cited at ₹129.75 with an intraday low near ₹125.85 and high near ₹142.10. Several threads framed ₹130-₹138 as the near-term “buy the dip” area, mainly because the price was back near the first support levels shared in technical summaries. Others took the opposite view, pointing to bearish positioning signals and the speed of the fall from the recent peak.

The week that drove the trend on social media

A popular recap circulating online listed a rapid sequence of highs and then a reversal. It cited Oct 5 as a fresh 52-week and all-time high around ₹137.5. It then referenced Oct 6 highs around ₹142.2 and an all-time high print around ₹141.4. The same recap said Oct 7 saw a new 52-week and all-time high near ₹150.8 alongside a record volume surge. After that, Oct 8 was described as a sharp decline of about 6.95% to ₹136.60 amid a broader market sell-off. Oct 9 continued the fall, with the close cited near ₹129.75. This sequence is central to why the stock is now being discussed as a momentum name that suddenly entered a dip zone. It also explains why social commentary is split between “pullback in an uptrend” and “trend reversal risk.”

Price, volume, and intraday volatility: what the tape showed

The data shared for 09-Oct-2026 highlighted heavy activity on both exchanges. NSE volume was cited near 17,770,995 shares, while BSE volume was shown near 955,793 shares. The NSE session range shared online was wide at ₹127.14 to ₹141.96, suggesting high intraday volatility. Another snippet referenced a “day’s range” of ₹135.12 to ₹141.96, which does not match the full low printed in the EOD data. Traders on forums used this mismatch to stress the importance of checking the exchange EOD range before acting on screenshots. The key takeaway from the tape discussion was not only the fall, but also the distance between open and close. Opening near ₹138.50 and closing near ₹129.55 reinforced the “sell-on-rallies” tone for the day. At the same time, high volume was used by dip buyers to argue the move was “supported by average to strong participation,” even though the day ended lower.

Technical levels shared online: supports, pivot, resistances

A widely shared technical summary listed a pivot near ₹139.10. It also showed first support at ₹130.71, second support at ₹124.88, and third support at ₹116.49. On the upside, first resistance was listed near ₹144.93, second resistance near ₹153.32, and third resistance near ₹159.15. With the close around ₹129.55, the stock sat just below the first support level shared, which is why the ₹130 area became a focal point. Posts also mentioned the stock trading “below CPR,” described as indicating bearishness. Another signal quoted was “trading below opening range,” also labelled bearish. Yet a separate summary counted “5 Bearish” and “11 Bullish” signals, implying mixed indicators depending on the tool used. In short, the levels being repeated most often are ₹124-₹131 as the immediate support band and ₹139-₹145 as the first area where sellers may reappear.

Earnings backdrop: strong growth numbers, but multiple versions

Part of the bullish argument on social media rests on sharp profit growth shared from recent quarters. One set of “green flags” claimed latest quarter sales rose 17.6% and profit rose 258.2%. Another widely shared line said “Quarterly PAT +258.21%,” echoing the same profit growth figure. Separately, a different summary called the latest Q1 FY27 results “strong,” claiming a 34.07% revenue increase and a 424.65% rise in net profit. Since these growth numbers differ, discussions often treated them as separate source outputs rather than a single reconciled fact set. The common theme across posts, however, was that profit growth was described as significantly higher than revenue growth, signalling operating leverage or base effects in the cited quarter. That narrative helped explain why some participants were willing to buy dips even after a sharp daily fall. At the same time, the same posts also flagged concerns about sustainability, noting that historical performance was described as “modest” in earlier periods.

Reported profit after tax figures cited in the feed

Some threads went beyond percentage growth and cited absolute PAT figures for recent quarters. These figures were shared as “Morepen Laboratories reports Profit after tax of Rs 539.99 Mln, in the June 2026 quarter,” along with “Rs 201.23 Mln” for March 2026 and “Rs 234.96 Mln” for December 2025. While social posts did not consistently provide the underlying revenue base alongside these numbers, they were used to frame June 2026 as a standout quarter versus the preceding two. Users also circulated longer-term history snapshots, claiming net sales rose from 768.54 crore in March 2019 to 1,811.58 crore in March 2025, and PAT increased from 28.84 crore to 118.02 crore over the same period. Those longer-term figures were presented as evidence of expansion in assets and liabilities as well. Because these values were taken from social summaries, traders treated them as directional rather than as a substitute for reading official filings. Still, the PAT sequence below was frequently reposted as a simple indicator of recent operating momentum.

Results timing: why “November results” keeps coming up

The current debate includes repeated references to results timing, including “November results,” largely because older corporate calendar entries are being reshared. One board meeting line showed “Date: 07 Nov ’25” and “Ex Date: 14 Nov ’25” for “Quarterly Results.” Another schedule table listed “Nov 13, 2025” (announced on Nov 6, 2025) as a board meeting for quarterly results. Separately, one Q-and-A style snippet claimed the “next results date” as August 4, 2026. That August date is also consistent with another calendar entry showing an Aug 3, 2026 board meeting for quarterly results. The overlap of old November entries and newer August entries has created confusion in comment threads, especially among users searching for “November results date.” What is clear from the chatter is that results events and board meetings are being treated as catalysts, even when the dates being circulated refer to different financial periods. For traders, the practical implication is that verifying the most recent exchange announcement is crucial before positioning purely around a calendar screenshot.

Ratings and verdicts: Hold vs Buy narratives

Another reason the stock is trending is the clash between rating summaries being shared. MarketsMOJO was cited as rating the stock “Hold,” last updated on 04 August 2026. At the same time, separate “expert verdict” cards circulating online described both near-term and long-term zones as “Buy.” One such card said a “Buy zone” was entered on 04 Aug ’26 at ₹69.18, and that price had moved ₹60.37 (87.27%) since then. These statements were used to justify why some traders see the current dip as a pullback within a bigger up move. Others countered that rating cards often lag price action and do not protect against sudden drawdowns after record highs. The debate is also influenced by technical labels like “below CPR,” which some interpret as a reason to wait for confirmation rather than catch a falling move. The net result is that social sentiment is not uniformly bullish or bearish, but highly tactical around specific levels.

Risks and concerns raised alongside the dip-buy thesis

Even among optimistic posts, concerns about durability of growth were explicitly mentioned. One snippet said sustainability remains a worry because historical performance has been modest, despite the recent turnaround-like growth claims. Another data point shared was that “Sales de-grew by 0.16%,” described as a revenue contraction for the first time in three years, based on consolidated financials. That line introduced a counter-narrative: that not every period shows clean top-line acceleration. Technical risk was also flagged through older references stating that as of Nov 19, 2025, the stock was in a bearish trend with moderate strength, supported by bearish MACD and moving averages, alongside mixed signals from KST. Valuation commentary also appeared, including a post saying that as of Nov 17, 2025, the stock was “fairly valued” with a PE ratio of 33.58, and a negative stock return of -38.87% versus the Sensex in that context. While these are older snapshots, they were reposted to argue that sentiment can shift quickly. For dip buyers, the key risk in the current setup is that recent highs and high volume can attract fast profit-booking if the broader market remains weak.

What traders are watching from here: ₹130-₹138 and ₹139-

The most repeated near-term plan on social media is simple: watch whether ₹130 holds and whether price can reclaim the pivot area around ₹139.10. The ₹130-₹138 range is being treated as the “decision zone,” with some looking for stabilization after the wide intraday swings. If price remains below the pivot and below CPR as stated in the posts, short-term traders expect selling pressure to persist on pullbacks. If the stock bounces, the first resistance zone being discussed is ₹144.93, which aligns with the area of recent highs after the reversal week began. The second resistance around ₹153.32 is also being watched because it sits closer to the recently cited peak zone. On the downside, ₹124.88 is the next support level commonly shared, and many posts imply that a break below it would weaken the dip-buy argument. Beyond price levels, users are tracking results-related board meeting updates and are rechecking calendars to separate old November entries from more recent events. Given the high volume and sharp weekly swings already seen, the crowd’s focus remains on risk control around predefined supports rather than broad predictions.